Furthermore, advancements in the field of EVs have provided novel opportunities to unravel the underlying mechanisms of AD, including measurements of phosphorylated tau (P-tau) in EVs17 in human CSF, and the discovery of novel potential biomarkers associated with AD19,20. The gene discussed is MAPT; the disease is Alzheimer disease.